October 23, 2019
FDA approves Trikafta to treat cystic fibrosis in patients older than 12
Vertex Pharmaceuticals got approval from the USFDA for Trikafta, for treating cystic fibrosis in patients older than 12
Pharmaceuticals, Biotechnology and Life Sciences
Vertex Pharmaceuticals got approval from the USFDA for Trikafta, for treating cystic fibrosis in patients older than 12
SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Maze Therapeutics, a company focused on translating genetic insights into new medicines, today announced that Jonathan Lim,…
WOONSOCKET, R.I. & TORONTO–(BUSINESS WIRE)–$ABAHF #AbacusHealthProducts–Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) today announced that…
NEW YORK–(BUSINESS WIRE)–#SICT2019—EpiVax Oncology, Inc., a precision cancer immunotherapy company, today announced that three abstracts highlighting its Ancer™ platform have…
– Revance’s long-acting neuromodulator DAXI will be featured in three abstracts and three oral presentations at the American Society for…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cedilla Therapeutics, a preclinical biotech company harnessing protein stability to create the next generation of targeted cancer therapies,…
White House Announcement made on October 22, 2019 GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that…
CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies…
— Once-Daily, Orally Administered CCR4 Antagonist Blocks Recruitment of Th2 Inflammatory Immune Cells — — Potential to Treat Allergic Inflammatory…
DUBLIN–(BUSINESS WIRE)–The “Global Schizophrenia Drugs (Orals & Injectables) Market: Insights, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s…